MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-10-0017265
Xymax Laboratories Private Limited
Xymax Laboratories Private Limited - pharma in Karnal, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.05 Cr
▲ 32% YoY
Net profit · FY 2024
₹57,836
Net margin 0.3%
EBITDA · FY 2024
₹8.03 Lakh
EBITDA margin 3.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Xymax Laboratories Private Limited
Data last updated:
Xymax Laboratories Private Limited is a private limited company based in Karnal, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U51909HR2017PTC069047. Its GSTIN is 06AAACX2266L1Z4 (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Deepak Arora and Bhawna Arora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No 1793 Sector – 6 Urban Estate, Karnal, Haryana, India – 132001.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.05 Cr, a growth of 32% compared to the previous year. For the same year it recorded a net profit of ₹57,836 (net margin 0.3%) and EBITDA of ₹8.03 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 47% over three years and 12% over five years.
Xymax Laboratories Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-10-0017265). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51909HR2017PTC069047
Registration Number 069047
Incorporation Date 17 May 2017
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-HR-10-0017265
Key People
Deepak Arora Director Bhawna Arora Director Recognitions & Rankings of Xymax Laboratories
Contact details
Xymax Laboratories Private Limited's registered office is in Karnal, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No 1793 Sector – 6 Urban Estate, Karnal, Haryana, India – 132001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Xymax Laboratories Private Limited, buy the company report.
Comprehensive company report
Xymax Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Xymax Laboratories is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Xymax Laboratories Private Limited, buy the company report.
Financials of Xymax Laboratories Private Limited
FY 2025 filings availableXymax Laboratories Private Limited reported revenue of ₹2.05 Cr (up 32% YoY) for FY 2024.
Revenue · FY 2024
₹2.05 Cr ▲ 32%
Net profit · FY 2024
₹57,836 margin 0.3%
EBITDA · FY 2024
₹8.03 Lakh margin 3.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 32%
3 years · compounded
▲ 47%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 24%
5 years · compounded
▲ 39%
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 32% growth in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.03 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹57,836 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Xymax Laboratories Private Limited, buy the company report.
Board of directors of Xymax Laboratories Private Limited
Xymax Laboratories has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Arora Also directs: Xymax Health Care Private Limited | Director | 17 May 2017 | 9 Years 5 Months | Current |
| Bhawna Arora | Director | 17 May 2017 | 9 Years 5 Months | Current |
Peer comparison
Xymax Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Swaranalaxmi Agro Products Private Limited | ₹2.05 Cr (FY 2024) | -26.0% | Burdwan, West Bengal, India | |||
| Tulips Hygiene Private Limited | ₹2.05 Cr (FY 2025) | -67.0% | Delhi, India | |||
| B B Constructions Ltd | ₹2.05 Cr (FY 2021) | 76.0% | Kolkata, West Bengal, India | |||
| Aaji Pharma Private Limited | ₹2.05 Cr (FY 2025) | 50.0% | Kolkata, West Bengal, India | |||
| Bluechip Asset Private Limited | ₹2.05 Cr (FY 2025) | 44.0% | Patna, Bihar, India | |||
| Xymax Laboratories Private Limitedthis company | ₹2.05 Cr (FY 2024) | ₹57,836 | 0.3% | 32.0% | Karnal, Haryana, India | |
| Skymarks Telecom Private Limited | ₹2.05 Cr (FY 2025) | 34.0% | Mumbai, Maharashtra, India | |||
| Southern Condiments Private Limited | ₹2.05 Cr (FY 2024) | 29.0% | Palakkad, Kerala, India | |||
| Blaack Forest Bakery Services Private Limited | ₹2.05 Cr (FY 2024) | 38.0% | Madurai, Tamil Nadu, India | |||
| A. N. Instruments Private Limited | ₹2.05 Cr (FY 2024) | 5.0% | Kolkata, West Bengal, India | |||
| Globlogis Private Limited | ₹2.05 Cr (FY 2023) | 137.0% | Delhi, India |
To see the full peer comparison of Xymax Laboratories Private Limited, buy the company report.
Auditor
Xymax Laboratories Private Limited is audited by AMIT VED & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMIT VED & ASSOCIATES | FY 2023 | 019057N |
Shareholding
The shareholding of Xymax Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Xymax Laboratories Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Xymax Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xymax Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Xymax Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAACX2266L1Z4 | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Xymax Laboratories Private Limited, buy the company report.
Recent activity
Xymax Laboratories Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Bhawna Arora was appointed as Director on 17 May 2017.
AGM
Xymax Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Xymax Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Appointed
Bhawna Arora was appointed as Director.
Appointed
Deepak Arora was appointed as Director.
Incorporation
17 May 2017
Xymax Laboratories Private Limited was registered on 17 May 2017 with Roc Haryana & aged 9 years 5 months as per MCA records.
Frequently asked questions
Xymax Laboratories is an active private limited company based in Karnal, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 May 2017 (9+ years old) and is registered under CIN U51909HR2017PTC069047.
Xymax Laboratories has 2 current directors:
- Deepak Arora - Director
- Bhawna Arora - Director
The latest financial statements of Xymax Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Xymax Laboratories is 06AAACX2266L1Z4, registered in Haryana.
The CIN (Corporate Identification Number) of Xymax Laboratories is U51909HR2017PTC069047. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xymax Laboratories was incorporated on 17 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Xymax Laboratories by revenue are Swaranalaxmi Agro Products Private Limited, Tulips Hygiene Private Limited, B B Constructions Ltd, Aaji Pharma Private Limited, Bluechip Asset Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Bhawna Arora was appointed as Director on 17 May 2017. Deepak Arora was appointed as Director on 17 May 2017.
Yes, Xymax Laboratories is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-10-0017265).
The registered office of Xymax Laboratories is at H.No 1793 Sector – 6 Urban Estate, Karnal, Haryana, India – 132001.
Xymax Laboratories operates in the pharma industry, in the drug formulation and development segment.